One-off item dents profits.
Richter to publish Q4 2018 earnings report this week.
New technical director to be appointed.
With Dutch Pantarhei Bioscience on sale of combined oral contraceptive.
Recommendation remains 'Hold', though.
Drop in Esmya sales weigh on results.
Pharma company to publish earnings report early on Thursday.
Pharmafarm is back in business.
Signs license and distribution agreement.
Women's Healthcare portfolio expanded.
J.P. Morgan also cuts rating.
U.S. FDA rejects application by Allergan.
Richter pampers shareholders with positive surprises.
There are some crucial questions, though.
Mol is also set to release earnings report this week.
European Commission takes decision.
For drug launch in the United States.
Hungary's leading pharma company reacts.
Recommendations for Esmya approved by CHMP.
To HUF 5,470 from HUF 5,695.